HE
Cybin Inc. Common Stock (HELP)
NASDAQ·Healthcare·Biotechnology
$5.18
-4.07%
Mkt Cap $269.43M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
Implied Upside
+324.7%
Consensus $22.00 vs current $5.18
NASDAQ·Healthcare·Biotechnology
$5.18
-4.07%
Mkt Cap $269.43M
Buy
4
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
+324.7%
Consensus $22.00 vs current $5.18